B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Citação
FRONTIERS IN CARDIOVASCULAR MEDICINE, v.10, article ID 1182530, 6p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-pro BNP) are cardiac biomarkers that are released in response to increased ventricular and atrial wall stress. Aortic stenosis (AS) leads to hemodynamic changes and left ventricular hypertrophy and may be associated with natriuretic peptide levels. Several studies have shown that increased natriuretic peptide levels are correlated with AS severity and can predict the need for intervention. It can be useful in risk stratification, monitoring follow-up, and predicting cardiovascular outcomes of patients with severe AS. This paper aims to summarize the evidence of the role of BNP and NT-pro BNP in AS, before and after intervention.
Palavras-chave
biomarkers, natriuretic peptides, B-type natriuretic peptide, aortic stenosis, aortic valve replacement
Referências
  1. Abramowitz Y, 2015, AM J CARDIOL, V116, P1904, DOI 10.1016/j.amjcard.2015.09.031
  2. Annabi MS, 2021, STRUCT HEART, V5, P319, DOI 10.1080/24748706.2021.1900630
  3. Antonini-Canterin F, 2008, INT J CARDIOL, V128, P406, DOI 10.1016/j.ijcard.2007.05.039
  4. Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34
  5. Bergler-Klein J, 2004, CIRCULATION, V109, P2302, DOI 10.1161/01.CIR.0000126825.50903.18
  6. Bottaro G, 2020, J CARDIOVASC ECHOGR, V30, P154, DOI 10.4103/jcecho.jcecho_13_20
  7. Capoulade R, 2017, EUR HEART J-CARD IMG, V18, P1378, DOI 10.1093/ehjci/jew288
  8. Capoulade R, 2014, HEART, V100, P1606, DOI 10.1136/heartjnl-2014-305729
  9. Chen S, 2020, EUR HEART J, V41, P958, DOI 10.1093/eurheartj/ehz892
  10. Cioffi G, 2011, HEART, V97, P301, DOI 10.1136/hrt.2010.192997
  11. Clavel MA, 2014, J AM COLL CARDIOL, V64, P1202, DOI 10.1016/j.jacc.2014.05.066
  12. Clavel MA, 2014, J AM COLL CARDIOL, V63, P2016, DOI 10.1016/j.jacc.2014.02.581
  13. Dahou A, 2018, JACC-CARDIOVASC IMAG, V11, P939, DOI 10.1016/j.jcmg.2017.06.018
  14. Dichtl W, 2008, AM J CARDIOL, V102, P743, DOI 10.1016/j.amjcard.2008.04.060
  15. Feuchtner GM, 2006, J HEART VALVE DIS, V15, P494
  16. Gerber IL, 2003, CIRCULATION, V107, P1884, DOI 10.1161/01.CIR.0000060533.79248.0C
  17. Goodman A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002561
  18. Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7
  19. Ikeda T, 1997, AM HEART J, V133, P307, DOI 10.1016/S0002-8703(97)70225-4
  20. Iwahashi N, 2011, J AM SOC ECHOCARDIOG, V24, P984, DOI 10.1016/j.echo.2011.03.012
  21. Jaiswal V, 2022, IJC HEART VASC, V43, DOI 10.1016/j.ijcha.2022.101125
  22. Katz M, 2012, J HEART VALVE DIS, V21, P331
  23. Lancellotti P, 2012, J AM COLL CARDIOL, V59, P235, DOI 10.1016/j.jacc.2011.08.072
  24. Lehtola H, 2022, J CARDIOVASC MED, V23, pE18, DOI 10.2459/JCM.0000000000001230
  25. Lim P, 2004, EUR HEART J, V25, P2048, DOI 10.1016/j.ehj.2004.09.033
  26. Lopes MAAAD, 2023, FRONT CARDIOVASC MED, V10, DOI 10.3389/fcvm.2023.1149613
  27. López-Otero D, 2013, INT J CARDIOL, V168, P1264, DOI 10.1016/j.ijcard.2012.11.116
  28. Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233
  29. Mizutani K, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006112
  30. Nishikimi T, 2021, J CARDIOL, V78, P269, DOI 10.1016/j.jjcc.2021.05.003
  31. Onishi H, 2022, ESC HEART FAIL, V9, P2474, DOI 10.1002/ehf2.13946
  32. Otto CM, 2021, J AM COLL CARDIOL, V77, P450, DOI 10.1016/j.jacc.2020.11.035
  33. Pedrazzini GB, 2008, AM J CARDIOL, V102, P749, DOI 10.1016/j.amjcard.2008.04.055
  34. Poulsen SH, 2007, J AM SOC ECHOCARDIOG, V20, P877, DOI 10.1016/j.echo.2006.11.020
  35. Qi W, 2001, AM HEART J, V142, P725, DOI 10.1067/mhj.2001.117131
  36. Redfors B, 2017, STRUCT HEART, V1, P18, DOI 10.1080/24748706.2017.1329959
  37. Ribeiro HB, 2014, AM J CARDIOL, V113, P851, DOI 10.1016/j.amjcard.2013.11.038
  38. Rubattu S, 2020, EUR HEART J, V41, P970, DOI 10.1093/eurheartj/ehz922
  39. Siontis GCM, 2019, EUR HEART J, V40, P3143, DOI 10.1093/eurheartj/ehz275
  40. Tsao CW, 2022, CIRCULATION, V145, pE153, DOI 10.1161/CIR.0000000000001052
  41. Tsutamoto T, 1997, CIRCULATION, V96, P509
  42. Vahanian A, 2022, EUR HEART J, V43, P561, DOI [10.1093/eurheartj/ehab395, 10.1016/j.rec.2022.05.006]
  43. Vale NC, 2018, REV PORT CARDIOL, V37, P67, DOI 10.1016/j.repc.2017.06.016
  44. Weber M, 2004, AM J CARDIOL, V94, P740, DOI 10.1016/j.amjcard.2004.05.055
  45. White Madeline, 2021, Med Sci (Basel), V9, DOI 10.3390/medsci9020029
  46. Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988